3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Myeloid
1
Conditions
Venous Thromboembolism
2
Neoplasms
1
Embolism
1
Interventions
Rivaroxaban
8
Surveys and Questionnaires
7
Heparin, Low-Molecular-Weight
5
apixaban
4
fludarabine
3
Blood Specimen Collection
3
pegfilgrastim
2
epoetin beta
2
Therapeutics
2
Polymerase Chain Reaction
2
Piperacillin, Tazobactam Drug Combination
2
Observation
2
Microarray Analysis
2
Melphalan
2
Influenza Vaccines
2
Immunoenzyme Techniques
2
Flow Cytometry
2
Epoetin Alfa
2
Data Collection
2
Dabigatran
2
Biopsy
2
ziprasidone
1
ribociclib
1
ravulizumab
1
palbociclib
1
oprelvekin
1
iron isomaltoside 1000
1
fludarabine phosphate
1
edoxaban
1
calcium heparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Dabigatran
×
Classical hematology
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled
NCT03965741
2021-11-30
PRACTISE
Bayer
Completed
97,765 enrolled